Skip to main content
OpenTrials

Clinical trial condition

Primary Myelofibrosis

Explore clinical trials studying Primary Myelofibrosis. Study availability and eligibility vary by location and protocol.

457 public trials 86 recruiting studies
Refine in advanced search Browse all conditions

Primary Myelofibrosis trial results

Completed

Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer

NCT00002504

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Bloomington Hospital Bloomington, Indiana, United States
  • St. Vincent Hospital and Health Care Center Research Department Indianapolis, Indiana, United States
  • Bergan Mercy Medical Center Omaha, Nebraska, United States
View Trial Details
Completed

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

NCT00361049

Conditions
Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +84 more
Locations
  • Geauga Regional Hospital Cleveland, Ohio, United States
  • Lake/University Ireland Cancer Center Cleveland, Ohio, United States
  • Ireland Cancer Center at University Hosptials Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • University Suburban Health Center Cleveland, Ohio, United States
View Trial Details
Completed

Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer

NCT00049465

Conditions
Adnexal Diseases, Behavior, Behavioral Symptoms, +105 more
Locations
  • Stanford University Medical Center Stanford, California, United States
  • AMC Cancer Research Center Denver, Colorado, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Shands Hospital and Clinics, University of Florida Gainesville, Florida, United States
View Trial Details
Completed

Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation

NCT00045292

Conditions
Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +108 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States
  • UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States
  • Baylor University Medical Center Dallas, Texas, United States
View Trial Details
Completed

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis

NCT00006367

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • Katmai Oncology Group Anchorage, Alaska, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • University of Illinois College of Medicine Chicago, Illinois, United States
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
View Trial Details

Related conditions